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Abstract
Background: There is a paucity of data on paediatric kidney disease in developing countries such as Malawi.
Descriptive research on kidney disease is essential to improving patient outcomes.
Methods: We conducted a cross-sectional study at a tertiary hospital in Malawi from 2012 to 2013. Children under
14 years with proteinuric kidney disease were enrolled from paediatric wards and outpatient clinics at Queen
Elizabeth Central Hospital (QECH). Demographic, clinical and laboratory data were collected from patients at
enrolment and at 3 months review at which point clinical status and disease outcome were ascertained.
Results: Thirty-four (22 male) patients were studied, mean age 8.54 (SD = 3.62 years). Glomerular disease (n = 25,
68%) was the most common presumed renal lesion at presentation. Nephritic syndrome (10) was characterised by a
lower baseline complement C3 than nephrotic syndrome (p = 0.0027). Seven (47%) cases of nephrotic syndrome
achieved complete remission. Eight (80%) cases of nephritic syndrome improved with supportive therapy. Nineteen
(56%) patients presented with clinically significant renal damage with eGFR< 60 ml/min/1.73m2. Six patients
presented in chronic kidney disease (CKD) stage 5 of unclear aetiology, five (83%) died. Three (9%) patients had
impaired kidney function and obstructive uropathy demonstrated on ultrasound, two recovered after surgery and
one died. Eight (24%) patients had acute kidney injury (AKI) due to primary kidney disease, three of these patients
progressed to CKD stage G3a. Seven (21%) patients were lost to follow up.
Conclusion: Kidney disease is a significant cause of mortality and morbidity in children at QECH. Less than half of
Nephrotic syndrome cases achieved complete remission. Mortality is highest in children with CKD of unclear cause.
Some patients with AKI secondary to primary renal disease progressed to CKD. Understanding the aetiology of
paediatric kidney disease and improving patient outcomes by developing enhanced diagnostic and clinical services
are priorities at QECH and within Malawi.
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Background
Kidney disease is a cause of significant morbidity and
mortality worldwide and the prevalence is rapidly in-
creasing globally [1]. Data from renal registries in devel-
oped countries shows that Congenital Anomalies of the
Kidney and Urinary Tract (CAKUT) predominate over
glomerular disease in children [2, 3]. Renal registries are
generally unavailable in developing countries [4]. How-
ever, studies done in Africa, Asia, Middle East and South
American developing countries all show similar findings
[5–7] where in contrast to high income settings, glom-
erular disease is the predominant cause of paediatric
kidney disease.. There is a high prevalence of infectious
diseases in developing countries which is a risk factor
for glomerular kidney disease [6–9].
The pattern of kidney disease varies in different geo-
graphical locations depending on ethnic backgrounds and
environmental factors [9]. However, the pattern of kidney
disease in children has not been widely studied in Sub
Saharan Africa, particularly Malawi and neighbouring
countries [10]. While the pattern of kidney disease in
Malawi might be similar to other regions in the
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developing world, the local environment might also lead
to a unique pattern of disease.
Detailed research on the aetiology and outcome of
paediatric kidney disease is critical to the development
of awareness among clinicians and policy makers and
will optimize patient outcomes and enable appropriate
resource allocation at QECH and nationally. Accord-
ingly, we described kidney disease in children with sig-




We conducted a cross-sectional study with a prospective
follow-up period of 3 months at the QECH paediatric
department. The primary aim of this study was to de-
scribe the clinical presentation and outcome of protein-
uric kidney disease in children presenting to a national
referral hospital in Malawi.
Enrolment was conducted over a 9-month study
period from June 2012 to March 2013, including a sea-
sonal period of high malaria and gastroenteritis inci-
dence. Patients were followed up at a routine paediatric
renal clinic at 3 months and outcome determined.
Transport money was provided for the patient and
one guardian to assure clinic attendance at 3 months.
Study site
QECH is a tertiary level facility that serves as the main
national referral centre for more than 10 districts in the
southern region.
The paediatric department provides free at the point
of access primary, secondary and tertiary care for neo-
nates and paediatric patients, seeing approximately
80,000 children and admitting 25,000 children per year.
Study population
All children less than 14 years with suspected kidney dis-
ease were recruited. Patients were referred to the study
team if there was clinical suspicion of kidney disease by
the admitting paediatric team. This included history,
examination and laboratory findings. These patients were
either admitted to QECH or were outpatients at the
QECH renal clinic. We enrolled all children with the fol-
lowing: significant proteinuria≥2+ (100-300 mg/dl) on
urine dipsticks [11] with or without abnormal estimated
GFR (eGFR). Patients were excluded if they: declined in-
formed consent or were unwilling to participate; were un-
willing or unable to receive clinical care for kidney
disease; had isolated urological abnormality (hydrocoele,
undescended testes); obstructive uropathy with no
proteinuria [12, 13].
Data collection
We collected patient demographic data combined with a
detailed clinical history and examination undertaken by
the study team (ZM).
Basic biochemical analysis was undertaken at QECH
main laboratory. Serum urea, creatinine, potassium, so-
dium, chloride and albumin were performed using photo-
metric method on Mindray BS-120 chemistry analyser
(Mindray, China). Full Blood Count was conducted on
SYSMEX KX-21 N (Sysmex, United States of America).
Hepatitis B surface antigen test (SD Bioline, India) and
Hepatitis C antibody tests (SD Bioline, India) were con-
ducted using rapid test strips as per manufacturer’s instruc-
tions. HIV rapid test were conducted using Determine test
strips (Determine, Japan) and Unigold (Trinity Biotech,
USA) test strips according to manufacturer’s instructions.
Paracheck plasmodium falciparum (parachekpf) rapid
diagnostic test (Orchid Biomedical system, India) was
used for malaria screening in all children with fever.
Malaria microscopy was conducted in all children with
positive malaria rapid diagnostic test.
Immunological assays were performed at the Immun-
ology Department, University of Birmingham, UK. The
initial ASOT assays were conducted using Rheumajet
ASO latex agglutination (Biokit, Spain) and then re-
peated on a SPA+ analyser (Binding Site, United King-
dom). IgG, IgA, IgM, C3, C4, Creatinine, CRP, Albumin
and Total protein were all measured on Cobas c501 tur-
bidimeter (Roche, Switzerland).
Siemens urine dipstick tests (Siemens, Germany) were
used for routine urinalysis. Urine microscopy was con-
ducted at the main QECH Laboratory. The remaining
urine specimen was used for urine schistosoma antigen
test (Rapid medical diagnostics, South Africa).
Renal ultrasound was conducted by a sonographer using
a Phillips HD3 machine (Phillips, Netherlands) using a
3.5 MHz probe. We measured kidney size using length in
centimetres and plotted the result against the participant’s
age. Kidney size was classified as large (> + 2 SD), small
(< − 2 SD) and normal (-2SD to +2SD) for age [9].
Clinical diagnosis and outcome
The final clinical diagnosis based on standard case defini-
tions was determined at the end of the follow up period for
those patients that completed the study (GD, ZM, DM).
Nutritional status
We classified nutritional status according to World
Health Organisation (WHO) criteria [14] using Z scores
to categorise the different anthropometric findings.
Renal function
Estimated GFR (eGFR) was calculated using the revised
Schwartz formula [15]:
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Hypertension
Blood pressure was classified according to the Fourth re-
port by the United States Working Group on Children
and Adolescents of the National High Blood Pressure
Education Program (NHBPEP) [16].
Diagnostic criteria
Patients were classified as nephrotic syndrome if they had
oedema, proteinuria ≥3+ (300-2000 mg/dl) on urine dip-
stick and hypoalbuminaemia (serum albumin≤25 g/L)
[11]. Patients were classified as nephritic syndrome if the
presented with oedema, proteinuria ≥2+ (100-300 mg/dl)
on urine dipstick, haematuria ≥1+ (5 to 10 red blood
cells), hypertension and high creatinine for age.
Acute kidney injury (AKI), where present, was consid-
ered a secondary diagnosis due to the primary renal dis-
ease. AKI was diagnosed as defined by 2012 KDIGO
AKI clinical practice guidelines [17]. We reviewed the
eGFR at baseline and at 3 months follow up. Resolution
of decreased eGFR at the 3 month follow up was classi-
fied as AKI.
Chronic kidney disease (CKD) was defined by KDIGO
criteria [18]. Chronicity was based on duration of symp-
toms or presumed due to findings of small kidneys on
KUB ultrasound and low eGFR.
Obstructive uropathy of varying aetiology with evi-
dence of kidney damage was defined as: hydronephrosis,
hydroureter, bladder wall thickening on renal ultrasound
scan and low eGFR for age.
The clinical and biochemical outcome of study pa-
tients was determined at 3 months.We recorded mortal-
ity during admission or during follow up period. We
classified the clinical status of patients as clinical deteri-
oration, clinical improvement and disease remission ac-
cording to the clinical diagnosis.
Clinical care
We provided routine clinical care to all study patients
according to local practice guidelines at QECH. Periton-
eal dialysis, haemodialysis and kidney biopsies were not
available to children in Malawi at the time of this study.
Statistical analysis
Data analysis was conducted using STATA 2014
(www.stata.com/stata14). The mean and standard devi-
ation were calculated for normally distributed data and
the median and inter-quartile range were determined for
non-parametric data. Statistical tests of significance were
applied to compare different groups. The chi-square test
for independence was conducted to compare categorical
variables.The Wilcoxon rank sum test was conducted
for non-parametric continuous variables to compare two
groups. Two sample t-test for independent samples was
conducted for parametric data. In order to compare
multiple groups of parametric continuous data, we con-
ducted a one way analysis of variance (ANOVA). We
conducted a paired t test to determine any differences
between paired observations at baseline and 3 months.
A p value < 0.05 was considered statistically significant.
Results
Forty two participants with suspected kidney disease
were screened, 35 participants with confirmed protein-
uric kidney disease were enrolled, 1 withdrew consent.
Twenty two (65%) children were male, the mean age
8.54 (SD = 3.62 years). Seventeen (50%) patients were
rural dwellers, defined as those residing at least 10 km
outside Blantyre urban area.
Clinical presentation
There was a reported history of recent infection in the
preceding 2 weeks in 14 (41%) patients. This included
history of sore throat, cough and skin rash. There was
recent history of consumption of traditional herbal med-
icines in 8 (24%) patients. Patients presented to hospital
at a median of 14 days (range 3–90 days) after the onset
of symptoms. Twenty-eight (82%) patients had micro-
scopic haematuria on urine dipstick. Eight (24%) patients
had moderate to severe anaemia (haemoglobin ≤9 g/dl).
Nineteen (56%) patients presented with clinically signifi-
cant renal impairment with eGFR< 60 ml/min/1.73m2.
The role of infections and inflammation
Six (18%) patients were positive for Falciparum malaria
on serology or microscopy. Nine (26%) patients were
positive for urine schistosoma antigen (Table 1). Schisto-
soma infection was more common in patients with
nephrotic syndrome although there was no statistical
significance (p = 0.55). ASOT levels at presentation were
significantly higher in nephritic syndrome compared to
the other conditions (p = 0.009). Twenty seven patients
tested negative for Hepatitis B and Hepatitis C viral ser-
ology, 7 had unknown status.
Nephrotic and nephritic syndromes
Glomerular disease (n = 25, 74%) was the most common
presumed renal lesion (Table 1). Fifteen (44%) patients pre-
sented with nephrotic syndrome, seven of these patients
had hypertension and/or microscopic haematuria at pres-
entation as well. Patients with nephrotic syndrome pre-
sented with severe hypoabuminaemia (p < 0.001) and low
serum IgG (p = 0.002) compared to the other groups. Ten
(29%) patients had nephritic syndrome, characterised by a
lower C3 (p = 0.003) at baseline than those with nephrotic
syndrome; C4 levels were normal. ASOT levels were
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significantly raised at baseline (p = 0.0012) in nepritic syn-
drome compared to nephrotic syndrome (Table 2), consist-
ent with an infective aetiology.
Eight cases of nephritic syndrome showed improve-
ment after supportive therapy with anti-hypertensive
therapy, diuretics and dietary restriction; 2 patients were
lost to follow-up. Seven cases of nephrotic syndrome
achieved complete remission after treatment with ste-
roids, 2 showed no remission, 1 died due to sepsis and 5
had no follow up data (Table 3).
Chronic kidney disease of unclear cause
Six (18%) patients presented in CKD stage 5 (Table 2)
of unclear cause. The median days between symptoms
and presentation were 36 days. These patients pre-
sented with a much lower estimated GFR (eGFR) than
other groups (p < 0.001). Four of these patients had
small kidneys on renal ultrasound scan. All patients
had significant proteinuria (> 2+) and microscopic
haematuria on urine dipstick suggesting a chronic
glomerulonephritis as the underlying aetiology. Five
patients died during the study and one had clinical
deterioration evidenced by a declining eGFR to lower
than 60 ml/min/1.73m2 (Table 3). None of these pa-
tients received renal replacement therapy. The aetiology
of renal disease was unclear in all these patients and
none had a kidney biopsy.
Obstructive Uropathy
Three (9%) patients had evidence of urinary tract ob-
struction. All patients had significant impairment of
kidney function with eGFR< 60 ml/min/1.73m2 and
significant proteinuria. Two of these patients were di-
agnosed to have posterior urethral valves on cystos-
copy and micturating cysto-urethrogram (MCUG), the
third patient had bladder outlet obstruction secondary
to urinary bladder mass. The latter patient died from
complications of kidney failure, whilst the other two
patients showed clinical improvement in GFR after
valve ablation.
Acute kidney injury
Eight (24%) patients had acute kidney injury due to the
various primary kidney diseases. Two nephritic syn-
drome, 3 nephrotic syndrome and 3 had obstructive uro-
pathy. All patients had AKI stage 3 (eGFR< 35 ml/min/
1.73m2 or serum Creatinine > 4.0 mg/dl). All patients
showed improvement in eGFR at 3 months. At follow
up, 5 patients had an eGFR above 60 ml/min/1.73m2,
one had normalization of eGFR above 90 ml/min/
Table 1 Clinical characteristics of patients at presentation and 3 month follow up. Figures are presented as Number (%), mean (SD)
and median (IQR)
Parameter (Reference range) All Patients Nephrotic Syndrome Nephritic Syndrome CKD Obstructive Uropathy
(n = 34) (n = 15) (n = 10) (n = 6) (n = 3)
Age, years 8.5 (3.6) 8.4 (3.8) 7.9 (2.6) 11.4 (1.5) 6.0 (6.6)
Gender
Male 22 (65%) 7 (47%) 8(80%) 4 (67%) 3 (100%)
Female 12 (35%) 8 (53%) 2 (20%) 2 (33%) 0 (0%)
HIV status
HIV negative 30 (88%) 13 (87%) 9 (90%) 5 (83%) 3 (100%)
HIV unknown 4 (12%) 2 (13%) 1 (10%) 1(17%) 0 (0%)
Albumin (35-50 mg/dl)
Baseline 21 (13–29) 13 (8–16) 25 (22–28) 25 (22–27) 30 (27–33)
3 months 33 (21–44) 36 (18–43) 38 (30–39) 31 (0) 39 (33–45)
Creatininea (0.2–1.1 mg/dl)
Baseline 0.9 (0.6–2.8) 0.6 (0.3–1.5) 0.8 (0.6–1.7) 8.0 (7.1–11.9) 2.8 (0.86–3.7)
3 months 0.8 (0.3–1.0) 0.9 (0.2–1.0) 0.6 (0.3–1.0) 10.5 (0) 0.7 (0.6–1.4)
eGFRa(65–135 ml/min/1.73m2)
Baseline 47 (26–108) 100 (47–175) 41 (33–95) 6 (4–9) 29 (10–46)
3 months 76 (56–220) 95 (73–275) 116 (49–164) – 57 (56–67)
Hypertension 19 (56%) 7 (47%) 7 (70%) 4 (67%) 1 (33%)
Schistosoma antigen positive 9 (26%) 5 (33%) 1 (18%) 2 (33%) 1 (33%)
Malaria positive 6 (18%) 0 (0%) 3 (27%) 3 (50%) 0 (0%)
CKD Chronic Kidney Disease unclear cause Malaria positive, RDT or microscopy, eGFR estimated glomerular filtration rate, Hb Haemoglobin
aAge and sex dependent
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1.73m2. Three patients had improvement of eGFR but
remained lower than 60 ml/min/1.73m2 (mean eGFR
54 ml/min/1.73m2), consistent with CKD stage G3a after
an episode of AKI.
Clinical outcomes
The clinical outcome of each condition is presented in
Table 3. CKD stage G4 to G5 carried the worst progno-
sis, whereas nephritic syndrome had the most favourable
outcome. Seven (21%) patients were lost to follow up,
five with nephrotic syndrome.
Discussion
To the best of our knowledge, this is the first study in
Malawi and the sub-region to present detailed clinical
and immunological data on proteinuric kidney disease in
a paediatric population.
Glomerular disease was the predominant cause of kidney
disease, similar to findings in multiple studies in Nigerian
tertiary facilities [19–24]. There was a clear immunological
delineation between cases of nephrotic and nephritic syn-
dromes. Nephritic syndrome biochemistry was consistent
with a post infectious aetiology suggested by significantly
high ASOT and low C3 at presentation, consistent with a
post infectious glomerulonephritis [25, 26]; C3 that in-
creased and normalised at follow up.
In this study, 47% of patients with nephrotic syndrome
were steroid responsive. Steroid sensitivity of nephrotic
syndrome in black African children seems to vary, while
previous studies reported low rates, current studies have
shown response rates as high as 75.9% in some parts of
Nigeria [27]. Seven of the 15 patients with nephrotic syn-
drome presented with unusual findings: they all had hyper-
tension, six had persistent microscopic haematuria and
four had renal insufficiency. These patients present a diag-
nostic challenge in the absence of kidney histopathology.
However, the classification of nephrotic syndrome was due
to no history of antecedent infection and low ASOT level,
no frank haematuria and normal complement C3 levels.
These findings may be consistent with the clinical pheno-
type of childhood focal segmental glomerulosclerosis
(FSGS). The identification of this population is very im-
portant due to the poor outcomes associated with FSGS in
black patients of African descent [28] who require more
aggressive treatment in order to mitigate the risk of pro-
gression to CKD and mortality. Additionally, a significant
proportion of our patients presented with advanced kidney
damage of unclear aetiology. Glomerular disease was sug-
gested by the presence of significant proteinuria and
microscopic haematuria. Chronicity of disease was based
on the finding of small kidneys in four of the six patients
on renal ultrasound scan. This suggests previously undiag-
nosed or sub-optimally managed glomerulonephritis. Pa-
tients with CKD stage G5 had the worst outcome due to
the unavailability of renal replacement therapy as a thera-
peutic option during the time of the study.
A significant proportion of patients in our study pre-
sented with AKI as a consequence of an underlying pri-
mary renal lesion. Acute kidney injury has been shown to
Table 2 Comparison of biochemical and immunological data in
cases of nephrotic and nephritic syndrome. Figures are presented




Nephrotic syndrome Nephritic syndrome p-value
(n = 15) (n = 10)
Age, years 8.4 (3.8) 7.9 (2.6) 0.61
HIV status
HIV negative 13 (87%) 9 (90%)
HIV unknown 2 (13%) 1 (10%)
Albumin (35–50 mg/dl)
Baseline 13 (8–16) 25 (22–28) < 0.001
3 months 36 (18–43) 38 (30–39) 0.26
Creatinine(0.2–1.1 mg/dl)a
Baseline 0.6 (0.3–1.5) 0.8 (0.6–1.7) 0.22
3 months 0.9 (0.2–1.0) 0.6 (0.3–1.0) 0.79
eGFR (65–135 ml/min/1.73m2)a
Baseline 100 (47–175) 40 (34–95) 0.95
3 months 95 (73–275) 116 (49–164) 0.83
Complement C3 (0.88–2.52 g/L)
Baseline 1.9 (1.5–2.5) 0.87 (0.4–1.6) 0.0027
3 months 1.6 (1.5–1.7) 1.7 (1.4–2.0) 0.23
Complement C4(0.12–0.75 g/L)
Baseline 0.5 (0.3–0.6) 0.31 (0.26–0.37) 0.96
3 months 0.3 (0.3–0.5) 0.31 (0.25–0.35) 0.54
CRP (0-10 mg/dl)
Baseline 6.7 (2.4–25.9) 4.9 (0.7–16.5) 0.99
3 months 0.3 (0–0.8) 1.3 (0.4–4.1) 0.99
ASOT (0-200 IU/ml)
Baseline 68 (19–78) 206 (131–528) 0.0012
3 months 70 (60–118) 163 (101–206) 0.0143
IgA (0.2–3.58 g/L)
Baseline 1.3 (1.0–1.8) 1.50 (1.3–1.7) 0.30
3 months 1.0 (0.9–1.5) 1.46 (1.3–1.6) 0.09
IgM (0.19–2.39 g/L)
Baseline 1.4 (1.3–1.7) 1.3 (1.1–1.7) 0.69
3 months 1.1 (1.0–1.6) 1.25 (1,0–1.6) 0.52
IgG (4.5–17.1 g/L)
Baseline 5.4 (4.4–12.9) 15.9 (12.4–19.1) 0.007
3 months 10.3 (10.1–11.7) 16.4 (13.8–19) 0.0006
Ig Immunoglobulin, ASOT Antistreptolysin O titre, CRP C-Reactive Protein, eGFR
estimated Glomerular filtration rate
aAge and sex dependent
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significantly increase the risk of developing chronic kidney
disease and progression to ESKD [29] which in a setting
without paediatric nephrologists and renal replacement
therapy leads to high mortality.
Patients with nephritic syndrome exhibited clinical im-
provement with supportive care. Three patients with neph-
ritic syndrome and AKI developed CKD, underscoring the
risk of progression to CKD in patients with nephritic syn-
drome and AKI. Obstructive uropathy secondary to poster-
ior urethral valves showed improvement after surgical
intervention, highlighting the benefit of specialist evaluation
and prompt referral to tertiary surgical services.
The overall outcome in patients in this study is poor.
Late presentation to hospital may have also contributed
to poor outcome, and low socio-economic status pos-
sibly contributed to the high rate of loss to follow up,
despite the provision of transport refunds to facilitate
clinic attendance. Public transport is unreliable in rural
areas and contributes to poor access to health care,
highlighting challenges in the provision of optimal health
services in a resource limited setting. Furthermore, some
patients who originally presented with oedema due to
nephrotic syndrome might not have returned once their
presenting oedema resolved as the family may have pre-
sumed the symptoms would not recur. Lack of aware-
ness of kidney disease and diagnostic limitations in
primary and secondary health facilities may have con-
tributed to late presentation which reduces opportunities
for early and specialist disease modifying interventions.
Our study also provides a clinical, immunological and
biochemical profile of children with proteinuric kidney dis-
ease at QECH. Poor socio-economic circumstances are
prevalent globally, suggesting our study may be applicable
in similar patient populations. Access to the immunological
diagnostic investigations we performed cannot easily be
sustained in a resource limited setting, reaffirming the im-
portance of good clinical history and examination as a diag-
nostic tool. Our data will add to knowledge of the
management of paediatric kidney disease and outlines its
poor outcomes in some groups but also the potential posi-
tive benefit that conservative care with accessible
interventions in Malawi and similar settings can provide,
especially in patients with glomerular lesions.
Our study is limited due to recruitment occurring dur-
ing office hours only since we were only able to include
referred cases rather than conducting active case finding
for renal disease across the whole of the in-patient service.
Thus, there is a degree of selection bias in our cohort and
the small sample size makes it difficult to ascertain the
true prevalence of paediatric proteinuric kidney disease
presenting to QECH. The study was conducted at a ter-
tiary hospital and thus our cohort is possibly not represen-
tative of kidney disease in district hospitals in Malawi. We
also recognise that the high loss to follow up may also lead
to bias. Finally, the lack of kidney histopathology prevents
a more detailed understanding of the specific glomerular
pathology in our cohort.
There is a pressing need for further research into paedi-
atric kidney disease in Malawi in order to raise awareness
of the local prevailing phenotype of paediatric kidney dis-
ease and improve patient outcomes. Supporting our study,
a larger study of AKI at QECH is currently underway.
Glomerular disease as the primary aetiology in our study
would be better assessed with renal histology but this ser-
vice for logistical, technical and safety reasons is unlikely
to be available in the foreseeable future.
Conclusion
Paediatric proteinuric kidney disease is a cause of signifi-
cant morbidity and mortality at QECH, and acute kidney
injury has been shown to cause CKD in some children. A
significant proportion of patients presented in CKD of un-
clear cause in a setting without renal replacement therapy
for children, with resulting high mortality. However, many
common paediatric renal conditions (nephritic/nephritic
syndrome) are amenable to treatment with simple, conser-
vative and surgical measures available at QECH and else-
where. Histolopathological characterisation of proteinuric
kidney disease in this region will lead to greater under-
standing of aetiology.
Raising awareness in developing countries is essential
to early identification and treatment of kidney disease.
Table 3 Clinical outcome at 3 months follow up. Figures are presented as number (%)
Outcomea All Patients Nephrotic syndrome Nephritic syndrome CKD Obstructive uropathy
Vital status (n = 34) (n = 15) (n = 10) (n = 6) (n = 3)
Alive 20 (59%) 9 (60%) 8 (80%) 1 (17%) 2 (67%)
Died 7 (21%) 1 (6.7%) 0 5 (83%) 1 (33%)
Completed study 27 (79%) 10 (63%) 8 (80%) 6 (100%) 3 (100%)
Alive at end of study
Improvement 17 (85%) 7 (78%) 8 (100%) 0 2 (67%)
Deterioration 3 (15%) 2 (22%) 0 1 (100%) 0
CKD Chronic kidney disease
aOutcome as defined in methods
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